Literature DB >> 15788029

Psychosocial assessment of patients who attend an accident and emergency department with self-harm.

W Barr1, M Leitner, J Thomas.   

Abstract

It has been recommended that all patients attending hospital accident and emergency departments in the United Kingdom (UK) with self-harm should be offered adequate psychosocial assessment to identify those at risk of completed suicide or repeated self-harm. This paper focuses on the extent to which this recommendation has been implemented in a large district general hospital in Wales, and compares the characteristics and hospital management of patients who received no specialist assessment with those who were assessed by a psychiatric liaison nurse or a psychiatrist. Data were routinely collected as part of the hospital annual audit procedure and confirm previous findings that guidelines for the general hospital management of self-harm patients have not been well implemented. Whilst we found some evidence that certain high risk patient groups were more likely to receive specialist assessment, this was far from universal. We conclude that if there is to be a reduction in the rate of suicide in Wales and the UK as a whole, it is crucial that services for people who self-harm are more appropriately targeted on patients who are at greatest risk.

Entities:  

Mesh:

Year:  2005        PMID: 15788029     DOI: 10.1111/j.1365-2850.2004.00804.x

Source DB:  PubMed          Journal:  J Psychiatr Ment Health Nurs        ISSN: 1351-0126            Impact factor:   2.952


  2 in total

1.  Risk of recurrent overdose associated with prescribing patterns of psychotropic medications after nonfatal overdose.

Authors:  Yasuyuki Okumura; Daisuke Nishi
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-02       Impact factor: 2.570

2.  Factors explaining variation in recommended care pathways following hospital-presenting self-harm: a multilevel national registry study.

Authors:  Eve Griffin; David Gunnell; Paul Corcoran
Journal:  BJPsych Open       Date:  2020-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.